Duchenne Muscular Dystrophy Research Program

The Duchenne Muscular Dystrophy Research Program (DMDRP) was established in fiscal year 2011 (FY11) to promote the understanding, diagnosis, and treatment of DMD. The FY11 appropriation is $4 million. The vision of the FY11 DMDRP is to extend and improve the function, quality of life, and life span for all individuals diagnosed with DMD. As such, the DMDRP mission is to fund research to accelerate the development and clinical testing of new therapeutics and increase our understanding of successes and failures of therapeutics in clinical trials.

• Congressional Appropriations
  • $4 million in FY11
  • $3.2 million in FY12
• FY12 DMDRP Funding Opportunities
• FY11 DMDRP Recommended for Funding List
• FY12 Integration Panel | FY11 Integration Panel
• FY11 Peer Review Participants (pdf)